ResearcherUniversity of SurreyActive in the last 2 years
Paul A. H. Moss
Matched on ORCID iD 0000-0002-6895-1967; OpenAlex author ID A5020948141. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 0, last author 4)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 13
2020: 1 paper · 2021: none · 2022: none · 2023: 3 papers · 2024: 2 papers · 2025: none · 2026: 1 paper
Papers 7
- IGF2BP3-mediated regulation of the RNA isoform and modification landscape in pancreatic cancer. Last author DOI 10.1038/s41388-026-03933-3↗
- Interplay in galectin expression predicts patient outcomes in a spatially restricted manner in PDAC. Co-author DOI 10.1016/j.biopha.2024.116283↗
- Involvement of the Gut Microbiome in the Local and Systemic Immune Response to Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/cancers16050996↗
- Tissue-Resident Memory T Cells in Pancreatic Ductal Adenocarcinoma Coexpress PD-1 and TIGIT and Functional Inhibition Is Reversible by Dual Antibody Blockade. Last author DOI 10.1158/2326-6066.cir-22-0121↗
- Pancreatic Exocrine Insufficiency and the Gut Microbiome in Pancreatic Cancer: A Target for Future Diagnostic Tests and Therapies? Co-author DOI 10.3390/cancers15215140↗
- Spatial determination and prognostic impact of the fibroblast transcriptome in pancreatic ductal adenocarcinoma. Last author DOI 10.7554/elife.86125↗
- NK cells in pancreatic cancer demonstrate impaired cytotoxicity and a regulatory IL-10 phenotype. Last author DOI 10.1080/2162402x.2020.1845424↗
Closest collaborators
The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Keith John Roberts · 7 shared papers, 2020–2026 · strength 1.23
- Paper IGF2BP3-mediated regulation of the RNA isoform and modification landscape in pancreatic cancer. DOI 10.1038/s41388-026-03933-3↗
- Paper Involvement of the Gut Microbiome in the Local and Systemic Immune Response to Pancreatic Ductal Adenocarcinoma. DOI 10.3390/cancers16050996↗
- Paper Pancreatic Exocrine Insufficiency and the Gut Microbiome in Pancreatic Cancer: A Target for Future Diagnostic Tests and… DOI 10.3390/cancers15215140↗
- Sarah F. Powell-Brett · 6 shared papers, 2023–2026 · strength 1.12
- Paper IGF2BP3-mediated regulation of the RNA isoform and modification landscape in pancreatic cancer. DOI 10.1038/s41388-026-03933-3↗
- Paper Involvement of the Gut Microbiome in the Local and Systemic Immune Response to Pancreatic Ductal Adenocarcinoma. DOI 10.3390/cancers16050996↗
- Paper Pancreatic Exocrine Insufficiency and the Gut Microbiome in Pancreatic Cancer: A Target for Future Diagnostic Tests and… DOI 10.3390/cancers15215140↗
- Hayden Pearce · 6 shared papers, 2020–2026 · strength 1.03
- Paper IGF2BP3-mediated regulation of the RNA isoform and modification landscape in pancreatic cancer. DOI 10.1038/s41388-026-03933-3↗
- Paper Involvement of the Gut Microbiome in the Local and Systemic Immune Response to Pancreatic Ductal Adenocarcinoma. DOI 10.3390/cancers16050996↗
- Paper Interplay in galectin expression predicts patient outcomes in a spatially restricted manner in PDAC. DOI 10.1016/j.biopha.2024.116283↗
- Sandra Margielewska‐Davies · 5 shared papers, 2020–2026 · strength 0.82
- Paper IGF2BP3-mediated regulation of the RNA isoform and modification landscape in pancreatic cancer. DOI 10.1038/s41388-026-03933-3↗
- Paper Interplay in galectin expression predicts patient outcomes in a spatially restricted manner in PDAC. DOI 10.1016/j.biopha.2024.116283↗
- Paper Tissue-Resident Memory T Cells in Pancreatic Ductal Adenocarcinoma Coexpress PD-1 and TIGIT and Functional Inhibition I… DOI 10.1158/2326-6066.cir-22-0121↗
- Wayne D. Croft · 4 shared papers, 2023–2026 · strength 0.71
- Paper IGF2BP3-mediated regulation of the RNA isoform and modification landscape in pancreatic cancer. DOI 10.1038/s41388-026-03933-3↗
- Paper Interplay in galectin expression predicts patient outcomes in a spatially restricted manner in PDAC. DOI 10.1016/j.biopha.2024.116283↗
- Paper Tissue-Resident Memory T Cells in Pancreatic Ductal Adenocarcinoma Coexpress PD-1 and TIGIT and Functional Inhibition I… DOI 10.1158/2326-6066.cir-22-0121↗
- Francesca Marcon · 4 shared papers, 2020–2024 · strength 0.57
- Paper Interplay in galectin expression predicts patient outcomes in a spatially restricted manner in PDAC. DOI 10.1016/j.biopha.2024.116283↗
- Paper Tissue-Resident Memory T Cells in Pancreatic Ductal Adenocarcinoma Coexpress PD-1 and TIGIT and Functional Inhibition I… DOI 10.1158/2326-6066.cir-22-0121↗
- Paper Spatial determination and prognostic impact of the fibroblast transcriptome in pancreatic ductal adenocarcinoma. DOI 10.7554/elife.86125↗
- James Michael Halle-Smith · 2 shared papers, 2023–2024 · strength 0.41
- Paper Involvement of the Gut Microbiome in the Local and Systemic Immune Response to Pancreatic Ductal Adenocarcinoma. DOI 10.3390/cancers16050996↗
- Paper Pancreatic Exocrine Insufficiency and the Gut Microbiome in Pancreatic Cancer: A Target for Future Diagnostic Tests and… DOI 10.3390/cancers15215140↗
- Lewis A Hall · 2 shared papers, 2023–2024 · strength 0.41
- Paper Involvement of the Gut Microbiome in the Local and Systemic Immune Response to Pancreatic Ductal Adenocarcinoma. DOI 10.3390/cancers16050996↗
- Paper Pancreatic Exocrine Insufficiency and the Gut Microbiome in Pancreatic Cancer: A Target for Future Diagnostic Tests and… DOI 10.3390/cancers15215140↗
- Gary Middleton · 3 shared papers, 2020–2023 · strength 0.41
- Paper Tissue-Resident Memory T Cells in Pancreatic Ductal Adenocarcinoma Coexpress PD-1 and TIGIT and Functional Inhibition I… DOI 10.1158/2326-6066.cir-22-0121↗
- Paper Spatial determination and prognostic impact of the fibroblast transcriptome in pancreatic ductal adenocarcinoma. DOI 10.7554/elife.86125↗
- Paper NK cells in pancreatic cancer demonstrate impaired cytotoxicity and a regulatory IL-10 phenotype. DOI 10.1080/2162402x.2020.1845424↗
- Nabeel Merali · 1 shared paper, 2023 · strength 0.19
- Adam Enver Frampton · 1 shared paper, 2023 · strength 0.19
- Oladimeji Abudu · 1 shared paper, 2024 · strength 0.17
- Helen Michelle McGettrick · 1 shared paper, 2024 · strength 0.17
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.